Skip to main content
Log in

Distribution of pentobarbital and diphenylhydantoin between plasma and cells in blood: Effect of salicylic acid, temperature and total drug concentration

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The binding of pentobarbital, diphenylhydantoin and salicylic acid to cells in blood was found to be independent of total drug concentration within therapeutic levels. Salicylic acid displaced pentobarbital and diphenylhydantoin from plasma protein binding sites, but high levels of salicylic acid had no effect on the distribution of the other two drugs to washed blood cells. Thus, in whole blood the presence of salicylic acid decreased the fraction of pentobarbital or diphenylhydantoin bound to plasma protiens and increased the fraction of the drug in plasma water and in blood cells. Diphenylhydantoin was shown not to be bound irreversibly to blood cells and equilibration in between the inside and outside of the cells was found to be rapid (within 5 min), even at high concentrations. Binding to washed blood cells was the same at 37°C and 25°C, in contrast to plasma protein binding. It is pointed out that these effects may cause certain analytical errors, resulting in changes in plasma concentration if plasma is separated at a low temperature.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lunde, P. K. M., Rane, A., Yaffe, S. J., Lund, L., Sjöqvist, F.: Plasma protein binding of diphenylhydantoin in man. Interaction with other drugs and the effect of temperature and plasma dilution. Clin. Pharmacol. Ther.11, 846–855 (1970)

    Google Scholar 

  2. Kurata, D., Wilkinson, G. R.: Erythrocyte uptake and plasma binding of diphenylhydantoin. Clin. Pharmacol. Ther.16, 355–362 (1974)

    Google Scholar 

  3. Ehrnebo, M., Odar-Cederlöf, I.: The binding of amobarbital, pentobarbital and diphenylhydantoin to blood cells and plasma proteins in healthy volunteers and uremic patients. Europ. J. clin. Pharmacol.8, 445–453 (1975)

    Google Scholar 

  4. McArthur, J. N., Dawkins, P. O., Smith, M. J. H.: The binding of indomethacin, salicylate and phenobarbitone to human whole blood in vitro. J. Pharm. Pharmacol.23, 32–36 (1971)

    Google Scholar 

  5. Ehrnebo, M., Agurell, S., Boréus, L. O., Gordon, E., Lönroth, U.: Binding of pentazocine to blood cells and plasma proteins in man. Clin. Pharmacol. Ther.16, 424–429 (1974)

    Google Scholar 

  6. Spector, R., Korkin, D. T., Lorenzo, A. V.: A rapid method for the determination of salicylate binding by the use of ultra filters. J. Pharm. Pharmacol.24, 786–789 (1972)

    Google Scholar 

  7. Meyer, M., Guttman, D.: The binding of drugs by plasma proteins. J. pharm. Sci.57, 895–918 (1968)

    Google Scholar 

  8. Brånstad, J. O., Meresaar, U., Agren, A.: Complex formation between macromolecules and drugs. VII. The binding of some barbiturates to human serum albumin (HSA) at varying pH. Acta pharm. suec.9, 129–134 (1972)

    Google Scholar 

  9. Schanker, L. S., Johnson, J. M., Jeffrey, J. J.: Rapid passage of organic anions into human red cells. Amer. J. Physiol.207, 503–508 (1964)

    Google Scholar 

  10. Antonini, E., Wyman, J., Moretti, R., Rossi-Fanelli, A.: The interaction of bromthymolblue with hemoglobin and its effect on the oxygen equilibrium. Biochem. biophys. Acta (Amst.)71, 124–138 (1963)

    Google Scholar 

  11. Kiehs, K., Hansch, C., Moore, L.: The role of hydrophobic bonding in the binding of organic compounds by bovine hemoglobin. Biochemistry5, 2602–2605 (1968)

    Google Scholar 

  12. Wind, M., Berliner, A., Stern, A.: The binding of phenothiazines to oxyhemoglobin A and S. Res. Commun. Chem. Pathol. Pharmacol.5, 759–766 (1973)

    Google Scholar 

  13. Bucci, E.: Electrostatic interaction of hemoglobin and benzenepentacarboxylate. Biochemistry13, 814–820 (1974)

    Google Scholar 

  14. Nilsson, S. O., Agren, A., Brånstad, J. O., Meresaar, U.: Complex formation between macromolecules and drugs. IX. The competition between two sulfa drugs and phenobarbital, pentobarbital or phenoxymethyl penicillin for binding sites on human serum albumin. Acta pharm. suec.10, 455–468 (1973)

    Google Scholar 

  15. Pagnini, G., DiCarlo, R., DiCarlo, F., Genazzani, E.: Enhancement of pentobarbital narcosis by drugs competing on the serum protein binding. Biochem. Pharmacol.20, 3247–3254 (1971)

    Google Scholar 

  16. Ehrnebo, M.: Pharmacokinetics and distribution properties of pentobarbital in humans following oral and intravenous administration. J. pharm. Sci.63, 1114–1118 (1974)

    Google Scholar 

  17. Odar-Cederlöf, I., Borgå, O.: Kinetics of diphenylhydantoin in uremic patients: Consequences of decreased plasma protein binding. Europ. J. clin. Pharmacol.7, 31–38 (1974)

    Google Scholar 

  18. Gilette, J. R.: Overview of drug-protein binding. Ann. N. Y. Acad. Sci.226, 6–17 (1973)

    Google Scholar 

  19. Klocke, R. A., Andersson, K. K., Rotman, H. H., Forster, R. E.: Permeability of human erythrocytes to ammonia and weak acids. Amer. J. Physiol.222, 1004–1013 (1972)

    Google Scholar 

  20. Ehrnebo, M., Agurell, S., Jalling, B., Boréus, L. O.: Age differences in drug binding by plasma proteins: Studies on human foetuses, neonates and adults. Europ. J. clin. Pharmacol.3, 189–193 (1971)

    Google Scholar 

  21. Anton, A. H., Corey, W. T.: Interindividual differences in the protein binding of sulfonamides: The effect of disease and drugs. Acta pharmacol. (Kbh.)29 (Suppl. 3), 134–151 (1971)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ehrnebo, M., Odar-Cederlöf, I. Distribution of pentobarbital and diphenylhydantoin between plasma and cells in blood: Effect of salicylic acid, temperature and total drug concentration. Eur J Clin Pharmacol 11, 37–42 (1977). https://doi.org/10.1007/BF00561786

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00561786

Key words

Navigation